CRISPR metabolic screen identifies ATM and KEAP1 as targetable genetic vulnerabilities in solid tumors.
Li H, Liu Y, Xiao Y, Wilson CN, Bai HJ, Jones MD, Wang S, DeVore JE, Maier EY, Durant ST, Boufraqech M, Weyemi U.
Li H, et al. Among authors: maier ey.
Proc Natl Acad Sci U S A. 2023 Feb 7;120(6):e2212072120. doi: 10.1073/pnas.2212072120. Epub 2023 Feb 1.
Proc Natl Acad Sci U S A. 2023.
PMID: 36724254
Free PMC article.